AT250138T
Angiogenesis inhibitory antibodies.
Abstract
(57) The antibody which contains a specific monoclonal antibody to fecundity / angiogensis nature human endothelial cells, such as summary human umbilical-vein endothelial cells and human umbilical artery endothelial cells, And the toxin substance of these antibodies or the conjugate with a sign is useful for prevention of angiogensis, or the medical treatment of an angiogensis dependence disease.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
17 members in 9 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| PL557392 | Australia | A | |
| 9300558 | Australia | W |
Members17
| Document | Office | Kind | |
|---|---|---|---|
| CA2148244A1 | Canada | A1 | |
| WO9410331A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5366194A | Australia | A | |
| EP0669988A1 | European Patent Office (EPO) | A1 | |
| JPH08502409A | Japan | A | |
| EP0669988A4 | European Patent Office (EPO) | A4 | |
| AU673865B2 | Australia | B2 | |
| US5677181A | United States of America | A | |
| US5874081A | United States of America | A | |
| SG78239A1 | Singapore | A1 | |
| EP0669988B1 | European Patent Office (EPO) | B1 | |
| AT250138TThis record | Austria | T | |
| ATE250138T1 | Austria | T1 | |
| DE69333209D1 | Germany | D1 | |
| JP3490443B2 | Japan | B2 | |
| DE69333209T2 | Germany | T2 | |
| EP0669988B2 | European Patent Office (EPO) | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 93923976
Titles2
- German
- ANGIOGENESE-INHIBIERENDE ANTIKÖRPER
- English
- ANGIOGENESIS-INHIBITED ANTIBODIES
Classification
- CPC, 5
- C07K16/28
- A61K38/00
- A61K47/6849
- A61P35/00
- C07K2317/73
- IPC, 9
- C12N15 02
- A61K38 00
- A61K39 395
- A61K47 48
- A61P35 00
- C07K16 28
- C12N5 10
- C12N5 20
- C12P21 08